Close Menu

NEW YORK (360Dx) – Laboratory Corporation of America today reported a 2 percent year-over-year drop in Q1 revenues.

LabCorp revenues for the quarter ended March 31 were $2.79 billion, down from $2.85 billion in the same quarter last year, and below the consensus Wall Street estimate of $2.83 billion.

The company saw a negative impact of almost 2 percent from the disposition of businesses and a negative impact of almost 1 percent from currency translation, which was balanced against a .5 percent positive impact from acquisitions, it said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.